Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Standard Biotools (LAB) Profit After Tax (2016 - 2026)

Standard Biotools has reported Profit After Tax over the past 16 years, most recently at $19.3 million for Q4 2025.

  • Quarterly Profit After Tax rose 170.96% to $19.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$71.9 million through Dec 2025, up 43.38% year-over-year, with the annual reading at -$74.9 million for FY2025, 17.64% up from the prior year.
  • Profit After Tax was $19.3 million for Q4 2025 at Standard Biotools, up from -$31.7 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $19.3 million in Q4 2025 and troughed at -$76.3 million in Q1 2022.
  • The 5-year median for Profit After Tax is -$21.9 million (2024), against an average of -$27.0 million.
  • Year-over-year, Profit After Tax crashed 305.33% in 2022 and then surged 170.96% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$13.8 million in 2021, then plummeted by 50.58% to -$20.8 million in 2022, then grew by 5.13% to -$19.8 million in 2023, then tumbled by 37.4% to -$27.2 million in 2024, then soared by 170.96% to $19.3 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Profit After Tax are $19.3 million (Q4 2025), -$31.7 million (Q3 2025), and -$33.5 million (Q2 2025).